The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis

Lung cancer has been a leading cause of cancer-related death for decades and therapeutic strategies for non-driver mutation lung cancer are still lacking. A novel approach for this type of lung cancer is an emergent requirement. Here we find that loss of LSAMP (Limbic System Associated Membrane Prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chao-Yuan, Wu, Kuan-Li, Chang, Yung-Yun, Liu, Yu-Wei, Huang, Yung-Chi, Jian, Shu-Fang, Lin, Yi-Shiuan, Tsai, Pei-Hsun, Hung, Jen-Yu, Tsai, Ying-Ming, Hsu, Ya-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234324/
https://www.ncbi.nlm.nih.gov/pubmed/34202934
http://dx.doi.org/10.3390/jpm11060578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234324/
https://www.ncbi.nlm.nih.gov/pubmed/34202934
http://dx.doi.org/10.3390/jpm11060578

Ejemplares similares